<SEC-DOCUMENT>0001829126-26-002204.txt : 20260312
<SEC-HEADER>0001829126-26-002204.hdr.sgml : 20260312
<ACCEPTANCE-DATETIME>20260311204420
ACCESSION NUMBER:		0001829126-26-002204
CONFORMED SUBMISSION TYPE:	425
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260312
DATE AS OF CHANGE:		20260311

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Voyager Acquisition Corp./Cayman Islands
		CENTRAL INDEX KEY:			0002006815
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		425
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42211
		FILM NUMBER:		26745268

	BUSINESS ADDRESS:	
		STREET 1:		C/O WINSTON & STRAWN LLP
		STREET 2:		800 CAPITOL ST., STE 2400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
		BUSINESS PHONE:		03477204333

	MAIL ADDRESS:	
		STREET 1:		C/O WINSTON & STRAWN LLP
		STREET 2:		800 CAPITOL ST., STE 2400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Voyager Acquisition Corp./Cayman Islands
		CENTRAL INDEX KEY:			0002006815
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		425

	BUSINESS ADDRESS:	
		STREET 1:		C/O WINSTON & STRAWN LLP
		STREET 2:		800 CAPITOL ST., STE 2400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
		BUSINESS PHONE:		03477204333

	MAIL ADDRESS:	
		STREET 1:		C/O WINSTON & STRAWN LLP
		STREET 2:		800 CAPITOL ST., STE 2400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
</SEC-HEADER>
<DOCUMENT>
<TYPE>425
<SEQUENCE>1
<FILENAME>voyageracq_425.htm
<DESCRIPTION>425
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
by Voyager Acquisition Corp<BR>
Pursuant to Rule 425 under the Securities Act of 1933<BR>
Subject Company: Voyager Acquisition Corp<BR>
Commission File No.: 001-42211</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOYAGER
      ACQUISITION CORPORATION ANNOUNCES REDEMPTION RESULTS IN CONNECTION WITH ITS BUSINESS COMBINATION WITH VERAXA BIOTECH AG</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BROOKLYN,
      NY March 11, 2026 --(GLOBE NEWSWIRE)-- Voyager Acquisition Corporation (NASDAQ: &#8220;VACHU,&#8221; &#8220;VACH,&#8221; &#8220;VACHW&#8221;) (&#8220;Voyager&#8221;
      or the &#8220;Company&#8221;) today announced that holders of 25,217,315 of the Company&#8217;s Class A ordinary shares (&#8220;Class
      A shares&#8221;) exercised their right to redeem their shares for a pro rata portion of the funds in the Company&#8217;s trust
      account, reflecting redemptions of approximately 99.67% of the total Class A shares outstanding in connection with the completion
      of the Company&#8217;s business combination (the &#8220;Business Combination&#8221;) pursuant to the business combination agreement
      between the Company, VERAXA Biotech AG (&#8220;VERAXA&#8221;) and the other parties thereto (the &#8220;Business Combination Agreement&#8221;).
      The 25,217,315 Class A shares which were submitted for redemption have not been withdrawn and will accordingly be redeemed pursuant
      to the option to redeem provided to holders of the Company&#8217;s Class A shares. As a result, assuming redemption elections are
      not withdrawn or reversed, following the effectuation of redemptions approximately $885,556 will remain in the Company&#8217;s
      trust account and 82,685 Class A shares will convert into shares of Veraxa Biotech Holding AG.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
      the Business Combination</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
      April&#160;22, 2025, VERAXA entered into the Business Combination Agreement, as amended. Upon closing of the Business Combination,
      the combined company is expected to become a publicly traded company listed on NASDAQ trading under the symbol &#8220;VRXA&#8221;.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
      VERAXA Biotech AG</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
      VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including
      bispecific ADCs, bispecific T cell engagers and other innovative formats. Powered by a suite of transformative technologies and
      guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into
      clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory,
      a world-renowned institution known for pioneering life science research and cutting-edge technology.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
      regular updates about VERAXA Biotech, visit <U>www.veraxa.com</U>. You can also follow us on LinkedIn.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
      Voyager Acquisition Corp.</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voyager
      is a special purpose acquisition company with a bold mission: to revolutionize the healthcare sector through a merger, stock purchase,
      or business combination. Our team of experienced executives includes unparalleled expertise in investing, operations, and medical
      innovation, supported by a vast network of connections. With these strengths, we not only seek to drive success but commit to scaling
      companies to unprecedented heights in the healthcare industry.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
      more information, please visit <U>https://www.voyageracq.com</U>.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Participants
      In the Solicitation</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voyager,
      VERAXA, and their respective directors, executive officers, other members of management, and employees may be deemed participants
      in the solicitation of proxies from Voyager&#8217;s stockholders with respect to the Business Combination. Investors and security
      holders may obtain more detailed information regarding the names and interests in the Business Combination of Voyager&#8217;s directors
      and officers in Voyager&#8217;s filings with the Securities and Exchange Commission (the &#8220;SEC&#8221;), including the preliminary
      proxy statement/prospectus, the definitive proxy statement/prospectus, amendments and supplements thereto, and other documents
      filed with the SEC. Such information with respect to VERAXA&#8217;s directors and executive officers is also included in the proxy
      statement/prospectus. You may obtain free copies of these documents as described below under the heading &#8220;Additional Information
      and Where to Find It.&#8221;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Solicitation</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
      press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in
      respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities
      of Voyager or VERAXA, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation,
      or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer
      of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
      Statements</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
      press release includes certain statements that may be considered forward-looking statements within the meaning of the federal securities
      laws. Forward-looking statements include, without limitation, statements about future events or Voyager&#8217;s or VERAXA&#8217;s
      future financial or operating performance. For example, statements regarding VERAXA&#8217;s anticipated growth and the anticipated
      growth and other metrics, statements regarding the benefits of the Business Combination, and the anticipated timing of the completion
      of the Business Combination are forward-looking statements. In some cases, you can identify forward-looking statements by terminology
      such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221;
      &#8220;project,&#8221; &#8220;strive,&#8221; &#8220;budget,&#8221; &#8220;forecast,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221;
      &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221;
      or &#8220;continue,&#8221; or the negatives of these terms or variations of them or similar terminology.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements regarding future events and the future results of Voyager and VERAXA are based on current expectations, estimates,
forecasts, and projections about the industry in which VERAXA operates, as well as the beliefs and assumptions of Voyager&#8217;s management
and VERAXA&#8217;s management. These forward-looking statements are only predictions and are subject to, without limitation, (i) known
and unknown risks, including the risks and uncertainties indicated from time to time in the final prospectus of Voyager relating to its
initial public offering filed with the SEC, and in the proxy statement/prospectus filed by Voyager and VERAXA on February&#160;19, 2026,
including those under &#8220;Risk Factors&#8221; therein, and other documents filed or to be filed with the SEC by Voyager; (ii) uncertainties;
(iii) assumptions; and (iv) other factors beyond Voyager&#8217;s or VERAXA&#8217;s control that are difficult to predict because they
relate to events and depend on circumstances that will occur in the future. They are neither statements of historical fact nor promises
or guarantees of future performance. Therefore, VERAXA&#8217;s actual results may differ materially and adversely from those expressed
or implied in any forward-looking statements and Voyager and VERAXA therefore caution against relying on any of these forward-looking
statements.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
      forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Voyager and its management
      and VERAXA and its management, as the case may be, are inherently uncertain and are inherently subject to risks, variability and
      contingencies, many of which are beyond Voyager&#8217;s or VERAXA&#8217;s control. Factors that may cause actual results to differ
      materially from current expectations include, but are not limited to: (i) the occurrence of any event, change or other circumstances
      that could give rise to the termination of the Business Combination Agreement and any subsequent definitive agreements with respect
      to the Business Combination; (ii) the outcome of any legal proceedings that may be instituted against Voyager, VERAXA, or others
      following the announcement of the Business Combination and any definitive agreements with respect thereto; (iii) the inability
      to complete the Business Combination due to the failure to obtain consents and approvals of the shareholders of Voyager, to obtain
      financing to complete the Business Combination or to satisfy other conditions to closing, or delays in obtaining, adverse conditions
      contained in, or the inability to obtain necessary regulatory approvals required to complete the transactions contemplated by the
      Business Combination Agreement; (iv) the failure to realize estimated shareholder redemptions, purchase price and other adjustments;
      and (v) other risks and uncertainties set forth in the filings by Voyager with the SEC. There may be additional risks that neither
      Voyager nor VERAXA presently know or that Voyager and VERAXA currently believe are immaterial that could also cause actual results
      to differ from those contained in the forward-looking statements. Any forward-looking statements made by or on behalf of Voyager
      or VERAXA speak only as of the date they are made. None of Voyager or VERAXA undertakes any obligation to update any forward-looking
      statements to reflect any changes in their respective expectations with regard thereto or any changes in events, conditions or
      circumstances on which any such statement is based.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
      Information and Where to Find It</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
      connection with the Business Combination Agreement, Voyager and VERAXA have filed a proxy statement/prospectus of Voyager, and
      will file other documents regarding the proposed transaction with the SEC. This communication is not intended to be, and is not,
      a substitute for the proxy statement/prospectus or any other document that Voyager has filed or may file with the SEC in connection
      with the proposed transaction. The definitive proxy statement and other relevant materials for the proposed transaction have been
      mailed or made available to stockholders of Voyager as of a record date to be established for voting on the proposed transaction.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Before
      making any voting or investment decision, investors and stockholders of Voyager are urged to carefully read the entire registration
      statement, the proxy statement/prospectus, and any other relevant documents filed with the SEC, as well as any amendments or supplements
      to these documents, and the documents incorporated by reference therein, because they will contain important information about
      Voyager, VERAXA, and the proposed transaction</B>. Voyager&#8217;s investors and stockholders and other interested persons can
      also obtain copies of the registration statement, the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus,
      other documents filed with the SEC that will be incorporated by reference therein, and all other relevant documents filed with
      the SEC by Voyager and/or VERAXA in connection with the transaction, without charge, once available, at the SEC&#8217;s website
      at <U>www.sec.gov</U>, or by directing a request to Voyager at the address set forth below.</FONT></P>

      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
       <TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact</B></FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VERAXA
            Biotech AG</B></FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 2%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voyager
            Acquisition Corp.</B></FONT></TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.&nbsp;Christoph
            Antz<BR>CEO<BR>Email: <U>antz@veraxa.com</U></FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&nbsp;Adeel
               Rouf</FONT></P>
               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO,
               and Director</FONT></P>
               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
               <U>adeel@voyageracq.com</U></FONT></P>
            </TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
               Media and Investors</B></FONT></P>
               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mario
               Brkulj</FONT></P>
               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valency
               Communications</FONT></P>
               <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
               <U>mbrkulj@valencycomms.eu</U></FONT></P>
            </TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
            <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #FFFFFF; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
         </TR>
      </TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></DIV>

    <!-- Field: /Page -->


   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
